The Oslo patient, diagnosed with HIV in 2006, underwent a bone marrow transplant in 2020 for a blood disorder. Following the procedure, doctors observed that the patient, now in his 60s, appeared to be cured of HIV, a finding now published in Nature Microbiology after a year of further monitoring and extensive testing. This case, meticulously documented and peer-reviewed, suggests that graft-versus-host disease following a transplant may be the key mechanism for eliminating infected cells. While not a viable treatment for all HIV patients, this research offers significant hope and momentum for developing future curative strategies for the virus.
Read More
In a remarkable case, a 63-year-old Norwegian man, referred to as the “Oslo patient,” appears to have been cured of his lifelong HIV infection. This unexpected outcome occurred following a stem cell transplant performed to treat a life-threatening blood cancer. The donor, the patient’s brother, possessed a rare CCR5-delta 32 mutation that confers natural resistance to HIV. Four years post-transplant and two years after discontinuing antiretroviral therapy, the patient remains free of the virus, offering significant insight into potential HIV cure strategies.
Read More
Recent research reveals a seventh individual has been successfully cured of HIV following a stem cell transplant, challenging previous assumptions. Unlike the first five individuals who received HIV-resistant stem cells, this patient, and the sixth, received non-resistant cells, indicating that HIV-resistance may not be essential for a cure. This suggests that the donor cells’ ability to eliminate the patient’s remaining immune cells may be crucial in preventing viral spread. This new understanding opens up the possibility that a broader range of stem cell transplants could potentially cure HIV, but that more research is needed, and that the patient’s and donor’s genetics may play a role.
Read More
Researchers at the Peter Doherty Institute have developed a novel mRNA delivery method using lipid nanoparticles (LNP X) to successfully reveal hidden HIV in human white blood cells, a major hurdle in developing an HIV cure. This method, detailed in *Nature Communications*, utilizes mRNA encased in these specially designed nanoparticles, instructing infected cells to expose the virus. While further research, including animal and human trials, is needed to determine efficacy, this breakthrough offers significant potential for eliminating the virus and could have broader implications for treating other diseases. The success rate observed in laboratory settings surpasses previous attempts, raising considerable hope for a functional HIV cure.
Read More
Bill Gates recently met with Donald Trump, discussing potential advancements in HIV and polio cures, finding the meeting highly productive and inspiring further collaboration. The meeting, praised by Gates, follows Trump’s claims of Gates’ seeking an audience and underscores a growing trend of prominent tech CEOs aligning with the incoming president. This gathering of tech leaders, including Elon Musk, Mark Zuckerberg, and Jeff Bezos, reinforces Trump’s assertion of widespread support amongst influential figures. The discussions highlighted the potential for accelerated vaccine innovation in combating HIV, similar to the approach used during the COVID-19 pandemic.
Read More
The confirmation of a fifth person cured of HIV is undeniably fantastic news. It represents a significant leap forward in medical science and offers a glimmer of hope for millions living with this virus. However, the reality is that this cure, achieved through a complex and risky stem cell transplant, remains far out of reach for the vast majority of those affected.
This breakthrough, while celebrated, highlights the significant hurdles still present. The procedure itself, typically used for cancer patients with no other options, carries a substantial risk of mortality. Even a 5% chance of death might be a gamble some individuals would take, considering the alternative, but it underscores the urgent need for a less dangerous, more accessible treatment.… Continue reading
John Q. Hosedrinker 
Matt Underwood